Uiuce modulab

From 2013.igem.org

(Difference between revisions)
Line 348: Line 348:
     <div class="collapse navbar-collapse navbar-ex1-collapse">
     <div class="collapse navbar-collapse navbar-ex1-collapse">
       <ul class="nav navbar-nav pull-right">
       <ul class="nav navbar-nav pull-right">
-
       <li><a href="https://2013.igem.org/Team:UIUC_Entrepreneurs">Home</a></li>
+
       <li><a href="https://2013.igem.org/Team:UIUC_Entrepreneurs"><font size="5"><b>Home</b></font></a></li>
-
     <li><a href="https://2013.igem.org/Uiuce_bus_model">Business Model</a></li>
+
     <li><a href="https://2013.igem.org/Uiuce_bus_model"><font size="5"><b>Business Model</a></li>
-
       <li><a href="https://2013.igem.org/Uiuce_modulab">ModuLab</a></li>
+
       <li><a href="https://2013.igem.org/Uiuce_modulab">ModuLab</a></li></b></font>
            
            
      
      
Line 360: Line 360:
      
      
       <li class="dropdown">
       <li class="dropdown">
-
                 <a class="dropdown-toggle" data-toggle="dropdown" href="#">About Us<b class="caret"></b></a>
+
                 <a class="dropdown-toggle" data-toggle="dropdown" href="#"><font size="5"><b>About Us</b></font><b class="caret"></b></a>
                 <ul id="menu2" class="dropdown-menu" role="menu" aria-labelledby="dropdownMenu">
                 <ul id="menu2" class="dropdown-menu" role="menu" aria-labelledby="dropdownMenu">
                           <li role="presentation"><a role="menuitem" tabindex="-1" href="https://2013.igem.org/Uiuce_our_mission">Our MIssion</a></li>
                           <li role="presentation"><a role="menuitem" tabindex="-1" href="https://2013.igem.org/Uiuce_our_mission">Our MIssion</a></li>

Revision as of 00:38, 29 October 2013

pic

ModuLab


Data

Overview


Modifying genomes has never been easier than it is today. No more harvesting your own restriction enzymes, DNA sequencing is outsourced, and biological parts are joining the registry by the hundreds. Synthetic biology is on the brink of becoming the next industrial revolution, but is still lacking on one major component that has catalyzed every industry in history to fame: automation. Vivosynth has conceived of the idea of a completely automated cloning machine ModuLab that can produce plasmids at a fraction of the cost at which you pay today.